Summary:
An open-label clinical trial to assess the safety and effectiveness of an investigational medication in patients with Schizophrenia
Qualified Participants Must:
Be 18 years of age or older
Be stable with respect to their schizophrenia
Qualified Participants May Receive:
Study medication and study-related medical care at no cost. Compensation for time and travel may also be provided.